Skip to content
For U.S. audiences only

FACTOR VIII TREATMENT RESOURCES

For more than 70 years, Takeda has been dedicated to pursuing advancements in hemophilia care and empowering our community to find the treatment that’s right for them.1

Takeda commitment icon.

Additional RESOURCES

These organizations offer support for people with bleeding disorders and can help you connect with others and better understand your treatment options for hemophilia A.

National Hemophilia
FoundationNational Hemophilia Foundation logo.Hemophilia Federation
of AmericaHemophilia Federation of America logo.Hemophilia Federation of America
Sangre LatinaHemophilia Federation of America Sangre Latina logo.

Sign up for more information

Learn more about factor treatment and living with hemophilia by signing up for MyFactorFam emails.

  1. Takeda demonstrates its long-standing commitment to advancing treatments for rare bleeding disorders with studies highlighting real-world evidence and investigational gene therapy at ASH 2019. Takeda Pharmaceuticals. December 9, 2019. Accessed August 13, 2021.https://www.takeda.com/newsroom/newsreleases/2019/takeda-demonstrates-its-long-standing-commitment/#about-takeda-hematology
About TakedaContact usTerms of usePrivacySitemap

©2021 Takeda Pharmaceuticals U.S.A., Inc. 300 Shire Way, Lexington, MA 02421. 1-877-TAKEDA-7 (1-877-825-3327). All rights reserved. TAKEDA and the TAKEDA Logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited. All other trademarks appearing herein are the property of their respective owners. US-NON-6007v1.0 10/21Unless otherwise indicated, images are not actual patients, caregivers or healthcare providers.